tiprankstipranks
BioView Ltd. (IL:BIOV)
TASE:BIOV
Israel Market
BIOV
Bio View
RESEARCH TOOLSreports

Bio View (BIOV) Income Statement

0 Followers

Bio View Income Statement

Last quarter (Q2 2025), Bio View's total revenue was ₪4.63M, a decrease of -45.62% from the same quarter last year. In Q2, Bio View's net income was ₪-2.28M. See Bio View’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₪ 19.93M₪ 25.66M₪ 34.77M₪ 29.14M₪ 30.51M
Gross Profit
₪ 8.75M₪ 15.56M₪ 21.38M₪ 16.67M₪ 17.59M
Operating Expenses
₪ 16.55M₪ 18.44M₪ 20.61M₪ 15.52M₪ 14.64M
Depreciation and Amortization
₪ 1.84M₪ 1.70M₪ 1.82M₪ 1.50M₪ 1.48M
EBITDA
₪ -5.96M₪ -943.00K₪ 2.93M₪ 2.61M₪ 4.45M
Operating Income
₪ -7.80M₪ -2.88M₪ 766.00K₪ 1.15M₪ 2.95M
Other Income/Expenses
₪ -1.34M₪ 19.00K₪ 31.00K₪ -276.00K₪ -267.00K
Pretax Income
₪ -9.15M₪ -2.86M₪ 797.00K₪ 875.00K₪ 2.68M
Net Income
₪ -15.33M₪ -3.15M₪ 383.00K₪ 587.00K₪ 2.18M
Per Share Metrics
Basic EPS
₪ -0.11₪ -0.02₪ 0.00₪ 0.05₪ 0.16
Diluted EPS
₪ -0.11₪ -0.02₪ 0.00₪ 0.05₪ 0.16
Weighted Average Shares Outstanding
 135.63M 140.07M 135.43M 13.91M 13.98M
Weighted Average Shares Outstanding (Diluted)
 135.63M 138.64M 139.08M 13.91M 13.98M
Currency in ILS

Bio View Earnings and Revenue History